PromarkerD kit version complete- commercial release imminent

Proteomics International is delighted to announce a major milestone in the on-going commercialisation of PromarkerD with the production of a new kit version of our predictive test for diabetic kidney disease.

The first batches of the immunoassay kit are due to ship within two weeks and follows completion of the complex manufacturing process that was required for a multi-target test such as PromarkerD.

The PromarkerD kit can be used by pathology laboratories globally, opening the door to new licensing opportunities around the world, and we look forward to providing further updates in the coming months.

Media release

  • This field is for validation purposes and should be left unchanged.